{
  "trial_id": "NCT03261466",
  "overall_assessment": "likely_eligible",
  "inclusion": [
    {
      "criterion": "homogeneous for number and sex of the subjects",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "randomization in a 1:1 to probiotic intervention group or placebo group",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "standard diet with 55-60% of carbohydrates, 25-30% lipids and 15% proteins",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "physical activity: all subjects will receive general recommendations about performing physical activity",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "timing: patients will be evaluated firstly at time of enrollment (V0) and, at the end of the first part of study (Study 1, V1)",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "biochemical evaluations will be completed after a 12-h overnight fast",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "anthropometric measures: height, weight, body mass index (BMI), waist and hip circumferences",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "blood pressure and heart rate will be measured",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "ultrasound evaluations will be performed",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "questionnaires will be obtained",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "patients will receive a supplementation of probiotic containing Bifidobacterium breve B632 and Bifidobacterium breve BR03, 15 gtt/die (3x108 CFU/die)",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "patients will receive a placebo for a total of 2 months of treatment",
      "label": "met",
      "evidence": "quote"
    }
  ],
  "exclusion": [
    {
      "criterion": "Adverse reactions to the product or component of the product (allergies\u2026)",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "Genetic obesity (Prader Willi syndrome, Down syndrome), Metabolic obesity (Laurence-biedl syndrome\u2026), endocrinological obesity (Cushinch syndrome, hypotiroidism)",
      "label": "triggers",
      "evidence": "none"
    },
    {
      "criterion": "Chronic diseases, hepatic or gastroenterological diseases",
      "label": "triggers",
      "evidence": "none"
    },
    {
      "criterion": "Medical treatment for chronic diseases",
      "label": "triggers",
      "evidence": "none"
    },
    {
      "criterion": "Probiotic or prebiotic therapies and antibiotic treatment",
      "label": "triggers",
      "evidence": "none"
    }
  ],
  "notes": "The patient has lower urinary tract symptoms including frequency, urgency, weak stream, incomplete emptying and intermittent flow for the past 9 months. He is otherwise healthy only using Vit D 1000 units daily.",
  "_meta": {
    "topic_id": "24",
    "trial_id": "NCT03261466",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}